Astec LifeSciences Limited has informed the Exchange about General Updates
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.2 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Astec LifeSciences Limited's Board of Directors met on April 27, 2026 and approved the audited financial results (standalone and consolidated) for Q4 and financial year ended March 31, 2026. The Statutory Auditors, B S R & Co. LLP, issued an unmodified (clean) opinion on both standalone and consolidated results, indicating no material concerns. The auditor's report confirms the financial statements give a true and fair view. The Board also fixed the 32nd AGM for July 31, 2026 and approved seeking shareholder approval via postal ballot for appointment of 4 directors (including Mr. Arijit Mukherjee as Executive Director and COO) and approval for material related party transactions for FY 2026-27.
The clean audit opinion is positive for shareholders as it indicates no material misstatements or concerns raised by auditors. The net loss shown in standalone results for FY 2025-26 may warrant monitoring. The director appointments and related party transaction approvals are routine governance matters.